Cost of Achieving HbA1c Treatment Targets and Weight Loss Responses with Once-Weekly Semaglutide Versus Dulaglutide in the United States - Concepedia

Concepedia

Publication | Open Access

Cost of Achieving HbA1c Treatment Targets and Weight Loss Responses with Once-Weekly Semaglutide Versus Dulaglutide in the United States

DOI Full Paper Access

16

Citations

18

References

2018

Year

Lars Wilkinson, Barnaby Hunt, Pierre Johansen, Neeraj N. Iyer, Tam Dang‐Tan, Richard F. Pollock

Diabetes Therapy

Abstract

Novo Nordisk A/S.

References

	Year	Citations

Page 1